GLN-TOPIRAMATE
GLENMARK PHARMACEUTICALS CANADA INC.
Quick answers
Is there a shortage of GLN-TOPIRAMATE in Canada?
No. There is no current shortage of GLN-TOPIRAMATE 25MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
PMS-TOPIRAMATE
PHARMASCIENCE INC
PRO-TOPIRAMATE
PRO DOC LIMITEE
TEVA-TOPIRAMATE
TEVA CANADA LIMITED
Other Products
TOPAMAX
JANSSEN INC
APO-TOPIRAMATE
APOTEX INC
TOPIRAMATE
SIVEM PHARMACEUTICALS ULC
DIN
02287765
Strength
25MG
Dosage Form
Tablet
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from GLENMARK PHARMACEUTICALS CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02466783
DIN 02462060
DIN 02421437
DIN 02421445
30MG · DIN 02518910
750MG · DIN 02528495
20MG · DIN 02544369
5MG · DIN 02519852
10MG · DIN 02519860
600MG · DIN 02410990
800MG · DIN 02411008
40MG · DIN 02469820